Kirk Barnes has a life sciences background with experience related to the pharmaceutical, biotechnology, nanotechnology, diagnostic, and medical device industries. His areas of expertise include sales, business development, marketing, training and leadership, lobbying, and managed markets. Kirk has startup experience both startup as well as small to large corporate experience.
Most recently, Kirk leads business development for TransPharMed, a consulting group focused on advancing sales solutions in the life sciences. Additionally, Kirk has served in various positions of increasing responsibility at these pharma/biotech sector companies: Inventiv Health, Zogenix, Takeda, Janssen Biotech and Pfizer.
Kirk led the business development initiatives for the NanoProfessor and NanoGuardian divisions of NanoInk, a private equity funded startup company commercializing research based nanotechnology from Northwestern University. Kirk was responsible for marketing the NanoProfessor Nanoscience Education Program as a new, hands-on nanotechnology education program for undergraduate and graduate students to teaching institutions in the United States, Asia, the Middle East, and India. At NanoGuardian, Kirk marketed innovative anti-counterfeiting solutions to pharmaceutical, defense, consumer and medical device industries in the United States, the European Union, and Asia.
Kirk also led lobbying initiatives in both the United States and European Union to incorporate nanotechnology based solutions in healthcare legislation related to the EU Falsified Medicines Directive, US e-Pedigree, and US FDA REMS.
Kirk served as a Board Member of the International Authentication Association (IAA), which monitored and provided guidance regarding authentication techniques and counterfeiting trends across the world. Kirk holds a bachelor’s degree in Business Economics from Florida A&M University.